Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast

Nanda Kumar Yellapu1, Madhusudana Pulaganti2, Suresh Babu Pakala3

  • 1a Biomedical Informatics Centre , Vector Control Research Centre (VCRC)-ICMR , Pondicherry 605006 , India.

Insights

P21-activated kinase-1 (PAK1) is crucial in breast cancer metabolism and signaling. Mapping its interactions reveals key partners like STAT3 and CCND1, offering new therapeutic targets for cancer control.

Area of Science:

  • Molecular Biology
  • Bioinformatics
  • Cancer Research

Background:

  • P21-activated kinase-1 (PAK1) is implicated in metabolic networks and cancer development.
  • Understanding PAK1's global network and interactions is vital for exploring its role in breast cancer.

Purpose of the Study:

  • To map the global network of PAK1 and identify its key molecular interactive partners in breast cancer.
  • To elucidate the biological functions and regulatory mechanisms of PAK1 in breast cancer.

Main Methods:

  • Acquired gene expression data for PAK1 from The Cancer Genome Atlas and GeneCards.
  • Utilized bioinformatics tools (DAVID, STRING, Cytoscape) for Gene Ontology, pathway analysis, and network construction.
  • Performed molecular modeling studies for PAK1 with interacting partners RHOA and STAT3.

Main Results:

  • Identified 91 PAK1-related genes associated with breast cancer.
  • PAK1 is linked to metabolic pathways, phosphorylation, signal transduction, apoptosis, and cancer cell signaling.
  • Key interacting genes include STAT3, CCND1, MAPK1, RHOA, and Catenin-beta-1, with direct interactions involving CCND1, MAPK1, and RHOA.
  • Molecular modeling revealed key interactive residues between PAK1, RHOA, and STAT3.

Conclusions:

  • The global expression map and interaction network of PAK1 provide insights into its functions in breast cancer.
  • Identified critical PAK1 interactions and residues that can inform the development of novel therapeutic strategies.
  • This study lays the groundwork for targeted therapies against breast cancer by understanding PAK1's molecular network.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K